HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mast cells are dispensable for normal and activin-promoted wound healing and skin carcinogenesis.

Abstract
The growth and differentiation factor activin A is a key regulator of tissue repair, inflammation, fibrosis, and tumorigenesis. However, the cellular targets, which mediate the different activin functions, are still largely unknown. In this study, we show that activin increases the number of mature mast cells in mouse skin in vivo. To determine the relevance of this finding for wound healing and skin carcinogenesis, we mated activin transgenic mice with CreMaster mice, which are characterized by Cre recombinase-mediated mast cell eradication. Using single- and double-mutant mice, we show that loss of mast cells neither affected the stimulatory effect of overexpressed activin on granulation tissue formation and reepithelialization of skin wounds nor its protumorigenic activity in a model of chemically induced skin carcinogenesis. Furthermore, mast cell deficiency did not alter wounding-induced inflammation and new tissue formation or chemically induced angiogenesis and tumorigenesis in mice with normal activin levels. These findings reveal that mast cells are not major targets of activin during wound healing and skin cancer development and also argue against nonredundant functions of mast cells in wound healing and skin carcinogenesis in general.
AuthorsMaria Antsiferova, Caroline Martin, Marcel Huber, Thorsten B Feyerabend, Anja Förster, Karin Hartmann, Hans-Reimer Rodewald, Daniel Hohl, Sabine Werner
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 191 Issue 12 Pg. 6147-55 (Dec 15 2013) ISSN: 1550-6606 [Electronic] United States
PMID24227781 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Carcinogens
  • Recombinant Proteins
  • activin A
  • Activins
  • 9,10-Dimethyl-1,2-benzanthracene
  • Proto-Oncogene Proteins c-kit
  • Tetradecanoylphorbol Acetate
Topics
  • 9,10-Dimethyl-1,2-benzanthracene
  • Activins (administration & dosage, deficiency, pharmacology)
  • Animals
  • Carcinogens
  • Carcinoma, Squamous Cell (blood supply, chemically induced, pathology)
  • Chemotaxis (drug effects)
  • Female
  • Humans
  • Injections, Intralesional
  • Mast Cells (drug effects, physiology)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mice, Transgenic
  • Neovascularization, Pathologic (pathology)
  • Neutrophil Infiltration
  • Papilloma (blood supply, chemically induced, pathology)
  • Proto-Oncogene Proteins c-kit (deficiency)
  • Recombinant Proteins (administration & dosage, pharmacology)
  • Skin (injuries, pathology)
  • Skin Neoplasms (blood supply, chemically induced, pathology)
  • Tetradecanoylphorbol Acetate
  • Wound Healing (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: